In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $152.11, denoting a +0.32% change from the preceding trading day.
Under current market conditions, our view is that playing defensive is more important than pursuing growth. Against this overall backdrop, this article explains why Johnson & Johnson is a good defensi
As demand for novel IBD treatments rises, investment in this dynamic sector could be rewarding. Some of the key players in the market are AbbVie (ABBV), J&J (JNJ), Lilly (LLY) and Pfizer (PFE).
Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Johnson & Johnson NYSE: JNJ,  Gilead Sciences Inc. NYSE: GILD and Bristol Myers Squibb Co. NYSE: BMY are among healthcare sector dividend-payers trading at low valuations relative to their earnings.
So far in 2023, 146 companies have gone public in the U.S. markets, down 16.09% from the same time last year. Although the IPO market has been choppy amid higher interest rates and broad equity market

10 Dividend Growth Stocks For November 2023

08:06am, Tuesday, 28'th Nov 2023
In my monthly series of 10 Dividend Growth Stocks, I rank a selection of Dividend Radar stocks and present the 10 top-ranked stocks for further research and possible investment. This month, I'm presen
U.S. stock market indexes are coming off of four positive weeks, but some top dividend stocks haven't kept pace. Johnson & Johnson stock is trading near a 52-week low despite strong growth from its me
There are few investors who have their every move followed and analyzed like Berkshire Hathaway (NYSE: BRK-A )(NYSE: BRK-B ) chairman and CEO Warren Buffett. That's because none have the sustained, lo

3 Biotech Stocks To Watch Before December 2023

10:38am, Monday, 27'th Nov 2023
Biotech stocks to check out in the stock market today.
For years now, a significant cohort of investors gravitated towards the allure of the S&P 500 index over individual stocks.

Buy 6 December Dividend Kings, 4 More On Watch

07:53am, Monday, 27'th Nov 2023
"There is only one-criterion to be included among the Dividend Kings: a publicly-traded company must increase its total fiscal-year dividend-payout for a minimum of 50 consecutive years." - Dogs of th
Amazon and Apple offer investors a solid growth track record -- and the potential for much more ahead. Add to these a couple of dividend giants and a biotech powerhouse and you have a great selection
Southern Co. has an excellent track record of growing value for its investors. Johnson & Johnson is a financial fortress with a strong record of creating shareholder value.
Ozempic could be reducing demand for weight-loss surgeries. It could thus become a new headwind for Johnson & Johnson and Intuitive Surgical.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE